InvestorsHub Logo
Followers 8
Posts 1427
Boards Moderated 0
Alias Born 06/30/2016

Re: doogdilinger post# 31520

Tuesday, 12/05/2017 8:40:43 AM

Tuesday, December 05, 2017 8:40:43 AM

Post# of 38634
Doog, well said. I agree. if one goes back and reviews the PR's they were seeking a partner in 2014 for Rexista AND Regabatin, Then in mid stream he changed the strategic plan and decided to go it alone. He thought he would get more money if he presented plug and play drugs and he decided to start his own manufacturing. We have been stalled ever since. Dr Odidi messed up. He is a brilliant scientist. the original plan was to formulate difficult to manufacturer drugs and license them out. That Plan would have worked. very little overhead and sustain off the profit sharing and milestone payments and license fees. Instead he thought he would be ripped off and people would steal his technology and he felt he would go it alone. Look at where we are. stuck in the mud.

2 Years and Regabatin has been sitting in a shelf. waiting for tens of millions of dollars to do the needed studies, while the competition now moves in got approved and now can hold up any approval by claiming patent infringement as well as generic competition after next year.

Podras, already proved in the lab just needs a small limited human study to prove concept and he could license it out for hundreds of drugs to be added as NDA supplement apparitions and probably be on market within 2 years and what is his plan? to submit 20 some NDA's as competition? LMAO, we all see how Rexista is going. In other words, its never going to happen. Not until he is ready to retire and someone else buys up the company.

but he will be happy thumping his chest claiming what a success he was. making his million a year in bonuses and salary and proudly claiming his 45 patents. as the stock sells for $1.50. I have seen it before. very intelligent people with no common sense thereby making dumb decisions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPCI News